Mitigating lung damage, mortality due to SARS-CoV-2Diseases, Conditions, Syndromes News

  • Post author:
  • Post published:October 5, 2021
  • Post category:Uncategorized

In a new paper, researchers at the University of Illinois Chicago report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and death in mice infected with the SARS-CoV-2 virus, which causes COVID-19 in humans.